Position in RXST
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,800,314
+$4,721,929 QoQ
Shares Held
995,916
+7726.5% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 151 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. RXST ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
5,542,438 | $502,920,823 | |
| 2 | BSX |
Boston Scientific Corp
|
2,414,223 | $103,039,037 | |
| 3 | GKOS |
GLAUKOS Corp
|
314,804 | $43,997,006 | |
| 4 | DXCM |
Dexcom Inc
|
532,804 | $35,884,349 | |
| 5 | EW |
Edwards Lifesciences Corp
|
344,361 | $31,150,895 | |
| 6 | PEN |
Penumbra Inc
|
90,520 | $28,581,689 | |
| 7 | SYK |
Stryker Corp
|
51,116 | $16,093,361 | |
| 8 | GMED |
Globus Medical Inc
|
188,541 | $14,896,623 |
All Filings in RXST
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,800,314 | 995,916 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $78,385 | 12,725 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $805,799 | 77,332 | Shares | Other | 2026-02-13 | |
| 2024-06-30 | $19,512,469 | 324,289 | Shares | Other | 2024-08-14 | |
| 2021-12-31 | $67,882 | 6,034 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $224,322 | 17,705 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||